Benjamin J. Hickey

2019

In 2019, Benjamin J. Hickey earned a total compensation of $2.2M as Former Senior Vice President, Chief Commercial Officer at Halozyme Therapeutics, a 37% decrease compared to previous year.

Compensation breakdown

Bonus$121,000
Non-Equity Incentive Plan$226,044
Option Awards$625,007
Salary$483,000
Stock Awards$625,008
Other$121,998
Total$2,202,057

Hickey received $625K in stock awards, accounting for 28% of the total pay in 2019.

Hickey also received $121K in bonus, $226K in non-equity incentive plan, $625K in option awards, $483K in salary and $122K in other compensation.

Rankings

In 2019, Benjamin J. Hickey's compensation ranked 5,442nd out of 13,971 executives tracked by ExecPay. In other words, Hickey earned more than 61.0% of executives.

ClassificationRankingPercentile
All
5,442
out of 13,971
61st
Division
Manufacturing
2,030
out of 5,701
64th
Major group
Chemicals And Allied Products
721
out of 2,200
67th
Industry group
Drugs
605
out of 1,886
68th
Industry
Biological Products, Except Diagnostic Substances
142
out of 389
64th

Pay ratio

Benjamin J. Hickey's Pay$2,202,057
Median Employee's Pay$238,096
Pay Ratio

9

to 1

In 2019, the annual total compensation of Benjamin J. Hickey was $2,202,057.

The annual total compensation of the median employee at Halozyme Therapeutics was $238,096.

The ratio of Benjamin J. Hickey's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on March 20, 2020.

Hickey's colleagues

We found four more compensation records of executives who worked with Benjamin J. Hickey at Halozyme Therapeutics in 2019.

2019

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2019

Alison Armour

Halozyme Therapeutics

Former Senior Vice President, Head of Research & Development

2019

Laurie Stelzer

Halozyme Therapeutics

Chief Financial Officer

2019

Harry Leonhardt

Halozyme Therapeutics

General Counsel

News

You may also like